Univ. of California Los Angeles

Los Angeles, California 90095

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, HER2-negative Breast Cancer Patients With Brain Metastases

Studies at this site

• A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases — Recruiting now
• Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer — Completed